ALURD · Allurion Technologies, Inc.
$4.36
-0.19 (-4.18%)
At close · Jul 29
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's recurring losses from operations incurred since inception, its expectation of continuing operating losses for the foreseeable future, the potential need to raise additional capital to finance its future operations, and noncompliance with certain financial covenants under its credit facilities, the Company has concluded that there is substantial doubt about its ability to continue as a going concern for a period of one year from the date that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are issued.”View the 10-Q filed May 15, 2026
Market Cap
$68.28M
Shares
15.01M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.36
Open$4.52
Day$4.36–4.55
52W$2.67–49.95
Avg vol 30d6K
Short int4K · 0.0% float · 1.0d
Short vol11%
Last earningsNov 12, 2025
DataAug 2023–Jul 2026
Filing10-Q · May 15
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−73%
below
Price vs 50-day avg
−48%
below
RSI (14)
38
neutral
MACD trend
Positive
52-week position
4%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−26%
trailing
6-month return
−80%
trailing
YTD return
−76%
this year
Relative strength
−86%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $8 › 200d $16 — 200d above 50d
Institutional flow
Distributing
-96% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.03% of float · ▼ -6.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 1-yr low, contrarian setup
Squeeze score
15
low risk · 0–100
Fundamentals
Revenue growth
−53%
Y/Y
Gross margin
63%
contracting
EPS growth
−19%
Y/Y
Free cash flow
$-29.6M
Balance sheet
$69.3M
net debt
Quant / Vol
risk profile
Volatility
185%
annualized · 1-yr
Max drawdown
−94%
past year
ATR
18.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Mar 31, 2025
Revenues
· 2025
Initiated
$3M
prior FY $15.23M
midpoint −80.3% Y/Y
Guided vs delivered
· last 2 settled
Revenues
2025
guided $3M
$15.23M
Beat +407.7%
Revenue
2024
guided $30M – $35M
$32.11M
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−73%
Bearish
Price vs 50-day avg
−48%
Bearish
RSI (14)
38
Neutral
MACD trend
Positive
Bullish
52-week position
4%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $8 › 200d $16 — 200d above 50d
Institutional flow
Distributing
-96% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.03% of float · ▼ -6.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $3
Now $4 · 4%
52-wk high $50
vs 200-day avg -73%
vs 50-day avg -48%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALURD
this stock
Allurion Technologies, Inc.
|
$68.28M | -76.4% | -39.9% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$186.84B | -13.4% | +5.7% | 30.1 | 1.4% |
|
SYK
Stryker Corp
|
$132.87B | +0.5% | +11.2% | 40.1 | 1.8% |
|
MDT
Medtronic plc
|
$111.21B | -8.1% | +8.4% | 23.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$68.43B | -51.7% | +5.5% | 19.3 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
1
- % held
- 0.0%
- Net QoQ
- -6.8M sh
- Top holder
- HARBOUR INVESTMENTS, INC.
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALURD | -3.1% | -26.2% | -80.0% | +9.0% | -76.4% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | -0.7% | -23.9% | -86.3% | +11.3% | -83.3% |